Lana Sinichkina and igor Svitlyk at Arzinger look into a question often asked lately by the community involved in clinicaltrilas for medicines; wheter individuals should enter into clinical trial services agreements with non-resident sponsors, and wethe the may enter into such relations without becoming entrepreneurs.
http://jforcs.com/jcs/wp-content/uploads/2013/10/Investigators…pdf